Total Payments
$8,796
2024 Payments
$788.18
Companies
50
Transactions
479
Medicare Patients
2,064
Medicare Billing
$161,952
Payment Breakdown by Category
Food & Beverage$8,778 (99.8%)
Education$18.04 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,778 | 475 | 99.8% |
| Education | $18.04 | 4 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,853 | 96 | $0 (2024) |
| Lilly USA, LLC | $1,360 | 100 | $0 (2024) |
| ABBVIE INC. | $954.77 | 48 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $629.39 | 29 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $576.20 | 24 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $498.89 | 19 | $0 (2024) |
| Exact Sciences Corporation | $261.54 | 14 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $230.64 | 12 | $0 (2024) |
| Abbott Laboratories | $219.15 | 12 | $0 (2023) |
| MannKind Corporation | $214.40 | 11 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $788.18 | 38 | ABBVIE INC. ($207.03) |
| 2023 | $1,557 | 82 | Novo Nordisk Inc ($439.73) |
| 2022 | $1,319 | 67 | Novo Nordisk Inc ($406.80) |
| 2021 | $1,890 | 100 | Boehringer Ingelheim Pharmaceuticals, Inc. ($236.46) |
| 2020 | $1,189 | 63 | Lilly USA, LLC ($269.53) |
| 2019 | $1,093 | 58 | Novo Nordisk Inc ($303.07) |
| 2018 | $298.20 | 22 | Lilly USA, LLC ($123.10) |
| 2017 | $662.13 | 49 | Novo Nordisk Inc ($200.59) |
All Payment Transactions
479 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/30/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $29.96 | General |
| Category: Diabetes | ||||||
| 08/16/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.71 | General |
| Category: Diabetes | ||||||
| 08/14/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $17.06 | General |
| Category: NEUROSCIENCE | ||||||
| 07/30/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $11.38 | General |
| Category: Diabetes | ||||||
| 07/30/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $3.50 | General |
| Category: Diabetes | ||||||
| 07/29/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $28.98 | General |
| Category: DIABETES | ||||||
| 07/24/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.41 | General |
| Category: Obesity | ||||||
| 07/22/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $13.69 | General |
| Category: Opioid Analgesic | ||||||
| 07/03/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $14.25 | General |
| Category: NEUROSCIENCE | ||||||
| 06/28/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.27 | General |
| Category: Diabetes | ||||||
| 06/28/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $11.66 | General |
| Category: Oncology | ||||||
| 06/25/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.10 | General |
| Category: DIABETES | ||||||
| 06/18/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $28.12 | General |
| Category: NEUROSCIENCE | ||||||
| 06/18/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.17 | General |
| Category: Diabetes | ||||||
| 06/17/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $20.02 | General |
| Category: Oncology | ||||||
| 05/28/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.88 | General |
| Category: Diabetes | ||||||
| 05/27/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $33.97 | General |
| Category: Diabetes | ||||||
| 05/23/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $21.63 | General |
| Category: Respiratory | ||||||
| 05/13/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $17.89 | General |
| Category: Opioid Analgesic | ||||||
| 04/22/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $25.73 | General |
| Category: Oncology | ||||||
| 04/11/2024 | ABBVIE INC. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $10.40 | General |
| Category: IMMUNOLOGY | ||||||
| 04/09/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $22.15 | General |
| Category: VACCINE | ||||||
| 04/08/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $24.62 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/28/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $19.50 | General |
| Category: Diabetes | ||||||
| 03/27/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $15.95 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 485 | 839 | $100,863 | $40,226 |
| 2022 | 7 | 533 | 849 | $105,876 | $41,136 |
| 2021 | 8 | 516 | 758 | $106,709 | $43,774 |
| 2020 | 5 | 530 | 881 | $100,447 | $36,816 |
Total Patients
2,064
Total Services
3,327
Medicare Billing
$161,952
Procedure Codes
27
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 153 | 285 | $63,840 | $26,141 | 40.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 91 | 128 | $19,328 | $7,592 | 39.3% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 98 | 179 | $4,117 | $1,640 | 39.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 12 | 12 | $4,092 | $1,617 | 39.5% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 33 | 65 | $5,850 | $1,554 | 26.6% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 12 | 12 | $2,688 | $1,187 | 44.1% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 86 | 158 | $948.00 | $494.69 | 52.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 130 | 253 | $56,672 | $22,326 | 39.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 126 | 189 | $28,539 | $11,620 | 40.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 38 | 38 | $12,958 | $4,470 | 34.5% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 90 | 143 | $3,289 | $1,318 | 40.1% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2022 | 17 | 25 | $2,250 | $539.54 | 24.0% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2022 | 95 | 164 | $984.00 | $513.53 | 52.2% |
| 83037 | Hemoglobin a1c level, by device for home use | Office | 2022 | 37 | 37 | $1,184 | $349.56 | 29.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 104 | 192 | $43,008 | $17,785 | 41.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 153 | 247 | $37,297 | $16,048 | 43.0% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 33 | 33 | $11,253 | $3,749 | 33.3% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 15 | 17 | $5,117 | $2,344 | 45.8% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 12 | 12 | $5,136 | $2,059 | 40.1% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 71 | 98 | $2,254 | $893.32 | 39.6% |
| 83037 | Hemoglobin a1c level, by device for home use | Office | 2021 | 64 | 65 | $2,080 | $611.73 | 29.4% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2021 | 64 | 94 | $564.00 | $285.36 | 50.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 162 | 266 | $40,166 | $14,504 | 36.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 87 | 139 | $31,136 | $11,413 | 36.7% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 70 | 70 | $23,870 | $8,538 | 35.8% |
About Dr. Stephanie Curry, M.D
Dr. Stephanie Curry, M.D is a Endocrinology, Diabetes & Metabolism healthcare provider based in Johnston, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/25/2011. The National Provider Identifier (NPI) number assigned to this provider is 1508152778.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stephanie Curry, M.D has received a total of $8,796 in payments from pharmaceutical and medical device companies, with $788.18 received in 2024. These payments were reported across 479 transactions from 50 companies. The most common payment nature is "Food and Beverage" ($8,778).
As a Medicare-enrolled provider, Curry has provided services to 2,064 Medicare beneficiaries, totaling 3,327 services with total Medicare billing of $161,952. Data is available for 4 years (2020–2023), covering 27 distinct procedure/service records.
Ad
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism
- Location Johnston, RI
- Active Since 06/25/2011
- Last Updated 07/21/2022
- Taxonomy Code 207RE0101X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1508152778
Products in Payments
- JARDIANCE (Drug) $780.44
- Ozempic (Drug) $647.34
- SYNTHROID (Drug) $543.64
- Saxenda (Drug) $423.14
- Rybelsus (Drug) $355.80
- XARELTO (Drug) $352.37
- TOUJEO (Biological) $293.70
- TRULICITY (Drug) $290.13
- Cologuard Collection Kit (Device) $261.54
- AFREZZA (Drug) $214.40
- XTAMPZA (Drug) $204.90
- MOUNJARO (Drug) $184.14
- SOLIQUA 100/33 (Biological) $183.92
- UBRELVY (Drug) $169.45
- NURTEC ODT (Drug) $154.11
- FARXIGA (Drug) $151.63
- INVOKANA (Drug) $146.52
- STIOLTO RESPIMAT (Drug) $137.94
- Synthroid (Drug) $134.21
- HUMULIN (Drug) $127.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.